MS Phoenix WinNonLin Project

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
SEMINAR ON NONCOMPARTMENTAL PHARMACOKINETICS
1-C: Renal and Hepatic Elimination
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Pharmacokinetics of Drug Absorption
Nonlinear pharmacokinetics
One-compartment open model: Intravenous bolus administration
Body clear- 1 Body clearance OCT 2010 PL Toutain.
Laplace transformation
November 2007 Metabolite Kinetics Theoretical Approach PHM324Y Guest Lecturer Dr. Jasmina Novakovic Apotex Inc, R&D.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Dosing Regimen Design Infusion regimen.
Gokaraju Rangaraju College of Pharmacy
LONGITUDNAL SECTION OF KIDNEY KLECOP, Nipani.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
JOURNAL CLUB PRESENTATION First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric.
Quantitative Pharmacokinetics
Nonlinear Pharmacokinetics
Nonlinear Pharmacokinetics Prepared By, Jahanvi H. Patel Roll No:09MPH103 Dept: Pharmaceutical Technology & Biopharmaceutics Guided By: Dhaivat C. Parikh.
Pharmacokinetics Introduction
Non-linear Pharmacokinetics Arthur G. Roberts. Linear Pharmacokinetics AUC dose K Cl dose [Drug] plasma time ln[Drug] plasma time Increasing Dose.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Atelier PK sur articles. 5 thèmes Absorption / biodisponibilité Métabolisme hépatique et effet de premier passage Les modèles in vitro d’étude de l’absorption.
PHARMACOKINETIC MODELS
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
One Compartment Open Model IV bolus
VARIABILITY IN PHARMACOKINETICS & PATIENT RESPONSE Dr. Mohd B. Makmor Bakry, Ph.D., RPh Senior Lecturer in Clinical Pharmacy Universiti Kebangsaan Malaysia.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Clearance Determinations Arthur G. Roberts. Routes of Elimination.
Errata Lecture 10 Slide 18 Rational because However.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
INTRODUCTION CLINICAL PHARMACOKINETICS

Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
MS WinNonLin Assignment
Nonlinear Pharmacokinetics
Pharmacokinetic Models
MS STUDENTS: QUESTIONS TO KNOW SECTION. Flurbiprofen misspelled!
DRUG INTERACTIONS I Lecture #36. Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism.
Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.
Grading Average = 91. Errata Michaelis-Menten Derivation KmKm k cat Formation of ES complex is rapid (k cat
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Clearance: basic concept (in vitro) Update OCT 2010.
Test Undergraduate – 24 Questions: Multiple Choice, Fill-in and T/F – 3 Problems MS – 3 Questions: Multiple Choice, Fill-in and T/F – MS grade: Undergrad.
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetics.
Pharmacology Phone Number: (203)
Allie punke Pharmacokinetics tutoring Fall 2016
Lecture-8 Biopharmaceutics
Pharmacokinetics.
Pharmacokinetics.
Hawler Medical University
Biopharmaceutics Chapter-6
Principle of Basic Clinical Pharmacokinetic parameters
Therapeutic Drug Monitoring chapter 1 part 1
Pharmacokinetics lecture 12 Contents ...
BIOAVAILABILITY.
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Therapeutic Drug Monitoring
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

MS Phoenix WinNonLin Project Due 9/21/15 Non-compartment analysis (NCA) of simulated oral plasma data Everyone uses drug. Plot and Table

Integration of Kinetic and Physiological Concepts Lecture #12 Integration  of  Kinetic  and  Physiological   Concepts

Clearance vs. V vs. t1/2 Increase V; Increase CL Decrease t1/2; Increase CL

k, t1/2 and AUC Unspoken Assumption: First Order Exponential Decay Kinetics

Future Current: Kinetics IV bolus dose We will Kinetics Extravascular Dose Constant-Rate Input Multiple-Doses Disease Non-linearities Drug Interactions

PK Parameters vs. Physiological Variables Primary PK Parameters Protein binding, enzyme activity, blood flows and partitioning Dose, V, CL, CLH, CLR, CLINT, dose, fu, blood-to-plasma equilibration ratio, Q, QR, QH Secondary PK Parameters Depend on Primary PK parameters Drug Concentrations, Rate Constants, AUC k = CL/V Observations AUC = Adose/CL CMAX = Adose/V Cu = fu (Adose/V)

Hepatic Extraction Ratio (EH) High EH Clearance cannot exceed hepatic blood flow (QH) Low EH

Hepatic Extraction Ratio (Eh) Enzymatic Activity/Concentration (CLint) Hepatic Blood Flow (Qh) Protein Binding (fu)

Low EH (Sensitive to Enzyme Activity) Inhibitor opioid analgesic drug Inducer Rifpampin http://www.ncbi.nlm.nih.gov/pubmed/17381666 https://en.wikipedia.org/wiki/Rifampicin (Antibiotic) Troleandomycin (macrolide antibiotic) https://en.wikipedia.org/wiki/Troleandomycin Cytochrome P450 3A4

Low EH (Sensitive to Enzyme Activity) Inhibited CLint =1 L/hr fu = 1 Hepatic Clearance (CLH) Induced Hepatic Extraction Ratio (EH)

Low EH (Insensitive to hepatic blood flow (QH)) CLint =1 L/hr fu = 1 Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)

low EH (Sensitive to Protein Binding) CLint =1 L/hr Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)

low EH (Sensitive to k and t1/2) CLint =1 L/hr Elim. Rate Constant (k) Half time (t1/2)

high EH (Insensitive to Enzyme Activity) Heart Drug P450 Inducer Pentobarbital is a sedative. https://en.wikipedia.org/wiki/Pentobarbital Pentobarbital Inhibitors? Cytochrome P450 (P450)

high EH (Insensitive to Enzyme Activity) Low Inhibition Recall: P450 Inhibitor P450 Inhibitor Cytochrome P450 3A4 inhibitor P450 = Cytochrome P450 synthetic opioid analgesic

high EH (Insensitive to Enzyme Activity) High Inhibition P450 inhibitor P450 = Cytochrome P450 synthetic opioid analgesic

High EH (Insensitive to Enzyme Activity) Induced Inhibited CLint =1000 L/hr fu = 1 Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH) Induced Inhibited

high EH (Sensitive to Blood Flow) Reduce QH Local Anesthetic Anti-hypertensive Anti-hypertensive

high EH (Sensitive to Blood Flow) CLint =1000 L/hr fu = 1 Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)

high EH (Insensitive to Protein Binding) CLint =1000 L/hr Hepatic Clearance (CLH) Hepatic Extraction Ratio (EH)

high EH (Insensitive to k and t1/2) CLint =1000 L/hr Elim. Rate Constant (k) Half time (t1/2)

Hepatic Clearance (CLh) Summary Low Eh Sensitive to enzyme activity/concentration (CLint) Insensitive to hepatic blood flow (Qh) Sensitive to protein binding (fu) Sensitive to k and t1/2 High Eh Insensitive to enzyme activity/concentration (CLint) Sensitive to hepatic blood flow (Qh) Insensitive to protein binding (fu) Insensitive to k and t1/2

a b a b

Excretion Rate

fu vs. Renal Excretion Rate Total Filtration Rate Secretion Filtration Rate Glomerulus Filtration Rate

fu vs. “Renal Excretion Rate” Excretion Rate in units of clearance (volume/hour) diuretic

Total Secretion Filtration Excretion Rate in L/hr units Excretion Rate in mg/hr units

Renal Extraction Ratio (ER)

Constant ER Renal Extraction Ratio Excretion Rate Total Excretion Rate Filtration Rate Secretion Rate

Constant EH

Relationships